Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-929-7 | CAS number: 25383-99-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation in bacteria in vitro (OECD 471): negative with and without metabolic activation
Mammalian cell micronucleus test in vitro (OECD 487): negative with and without metabolic activation
Gene mutation in mammalian cells in vitro (OECD 476): negative with and without metabolic activation
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 Sept - 02 Oct 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted in 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- adopted in 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon for S. typhimurium strains and trp operon for E. coli strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : Cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital/β-naphthoflavone
- concentration or volume of S9 mix and S9 in the final culture medium: 500 µL
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): Each batch of S9 was routinely tested for its capability to activate the known mutagens benzo[a]pyrene and 2-aminoanthracene in the Ames test.
- Lot no.: 060619K
- protein concentration: 29.3 mg/mL - Test concentrations with justification for top dose:
- Pre-experiment/experiment I:
3, 10, 33, 100, 333, 1000, 2500, and 5000 μg/plate with and without metabolic activation
Experiment II:
Strains TA 1535 and WP2 uvrA: 33, 100, 333, 1000, 2500 and 5000 μg/plate with and without metabolic activation
Strains TA 1537 and TA 98: 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate with and without metabolic activation
Strain TA 100: 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate with and without metabolic activation
5000 µg/plate was selected as the highest test concentration based on the results of a range-finding study (pre-experiment / experiment I). Since toxic effects were observed in the pre-experimentexperiment I, a minimum of six concentrations were tested in experiment II. The concentration range included two logarithmic decades. - Vehicle / solvent:
- - Vehicle used: deionised water
- Justification for choice of solvent/vehicle: The solvent was chosen based on the solubility properties of the test substance and its nontoxicity to the bacteria. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine (4-NOPD), 2-aminoanthracene (2-AA)
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicate
- Number of independent experiments: two (pre-experiment/experiment I and experiment II)
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable): 10E08 - 10E09 cells/mL
- Test substance added in agar (plate incorporation) in pre-experiment/experiment I; preincubation in experiment II
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 48 h
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: Inspection of the background growth inhibition - Evaluation criteria:
- The test material may be considered positive in this test system if the following criteria are met:
Two-fold or above (strains TA 98, TA 100, and WP2 uvrA) or threefold or above (strains TA 1535 and TA 1537) increases in mean revertant numbers must be observed at two consecutive dose levels or at the highest practicable dose level only. An increase of revertant colonies equal or above the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment. In addition, there must be evidence of a dose-response relationship showing increasing numbers of mutant colonies with increasing dose levels. All cultures must demonstrate the characteristic mean number of spontaneous revertants in the vehicle controls. - Statistics:
- Mean values and standard deviation were calculated.
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- precipitation was observed at concentrations of 2500 µg/plate and above (experiment I + experiment II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity was observed at concentrations of 5000 µg per plate (-S9/+S9, experiment I) and 1000 µg/plate and above (-S9, experiment II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity was observed at concentrations of 5000 µg per plate (-S9, experiment II); precipitation at 2500 µg/plate and above in both experiments.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity was observed at concentrations of 333 µg per plate and above (-S9, experiment I), 2500 µg/plate and above (+S9, experiment I) and 1000 µg/plate and above (-S9, experiment II); precipitation at 2500 µg/plate and above in experimetn II.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- precipitation was observed at concentrations of 2500 µg/plate and above (experiment I + experiment II)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: The test substance is poorly soluble in water; therefore, it was suspended in deionised water.
- Precipitation and time of the determination: The test item precipitated in the overlay agar in the test tubes from 1000 to 5000 μg/plate in experiment I and from 2500 to 5000 μg/plate in experiment II. Precipitation of the test item in the overlay agar on the incubated agar plates was observed from 2500 to 5000 μg/plate in both experiments. The undissolved particles had no influence on the data recording.
RANGE-FINDING/SCREENING STUDY
To evaluate the toxicity of the test item a pre-experiment was performed with all strains. Eight concentrations in the range 3 - 5000 µg/plate were tested for toxicity and mutation induction with three plates each. The experimental conditions in this pre-experiment fulfilled all acceptance criteria. Therefore, the pre-experiment was also considered as experiment I. Since toxic effects were observed in the pre-experiment/experiment I, a minimum of six concentrations were tested in experiment II. 5000 μg/plate was chosen as maximal concentration.
STUDY RESULTS
- Concurrent vehicle negative and positive control data : Please refer to 'Any other information on results incl. tables'.
Ames test:
- Individual plate counts : Please refer to 'Any other information on results incl. tables'.
- Mean number of revertant colonies per plate and standard deviation: Please refer to 'Any other information on results incl. tables'.
HISTORICAL CONTROL DATA (with ranges, means and standard deviation, and 95% control limits for the distribution as well as the number of data)
Please refer to 'Any other information on results incl. tables'. - Conclusions:
- Interpretation of results: negative
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 31 Oct - 19 Dec 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Version / remarks:
- adopted in 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Type of assay:
- in vitro mammalian cell micronucleus test
- Target gene:
- Not applicable
- Species / strain / cell type:
- lymphocytes: cultured peripheral human lymphocytes
- Details on mammalian cell type (if applicable):
- CELLS USED
- Suitability of cells: Human lymphocytes are the most commonly used cells in the micronucleus test and have been used successfully for a long time in in vitro experiments. They show stable spontaneous micronucleus frequencies at a low level.
For lymphocytes:
- Sex, age and number of blood donors: Experiment I: one female, 28 years; Experiment II: one male, 28 years; donors were healthy, non-smoking and did not receive medication
- Whether whole blood or separated lymphocytes were used: whole blood
- Whether blood from different donors were pooled or not: no
- Mitogen used for lymphocytes: Phytohemeagglutinine (PHA)
MEDIA USED
- Type and composition of media, CO2 concentration, humidity level, temperature:
- Dulbecco's Modified Eagles Medium/Ham's F12 (DMEM/F12, mixture 1:1) supplemented with 200 mM GlutaMAX™,
- penicillin/streptomycin (100 U/mL/100 μg/mL),
- PHA (3 μg/mL),
- 10 % fetal bovine serum (FBS),
- 10 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid),
- heparin (125 U.S.P.-U/mL).
In the pulse exposure experiment (pre-experiment/experiment I), for the treatment with metabolic activation 50 μL S9 mix per mL culture medium was added. In both experimens (pulse exposure = pre-experiment/experiment I and continuous exposure = experiment II), after exposure to the test substance, cells were resuspended in and washed with "saline G" (pH 7.2, containing 8000 mg/L NaCl, 400 mg/L KCl, 1100 mg/L glucose.H2O, 192 mg/L Na2HPO4.2 H2O and 150 mg/L KH2PO4).
- Incubation conditions: All incubations were done at 37 °C with 5.5% CO2 in humidified air. - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: Cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital/β-naphthoflavone
- concentration or volume of S9 mix and S9 in the final culture medium: 500 µL
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): Each batch of S9 was routinely tested for its capability to activate the known mutagens benzo[a]pyrene and 2-aminoanthracene in a bacterial reverse mutation assay (Ames test).
- Lot no.: 050919B
- protein concentration: 30.2 mg/mL - Test concentrations with justification for top dose:
- Pre-experiment/experiment I (4 h exposure): 4.4, 7.7, 13.5, 23.7, 41.5, 72.6, 127, 222, 667, 2000 µg/mL, with and without S9 mix
Experiment II (20 h exposure): 26.0, 39.0, 58.5, 87.8, 132, 198, 296, 444, 667, 1000 µg/mL, without S9 mix
Considering the molecular weight of the test item (378.52 g/mol), 2000 μg/mL was chosen as top concentration in the pre-experiment. Precipitation was observed at 127 μg/mL and above in the absence of S9 mix and at 72.6 μg/mL and above in the presence of S9 mix. Since in the pre-experiment the cultures fulfilled the requirements for the evaluation of cytogenetic effects of the test substance, this preliminary test was designated experiment I. Due to the precipitation observed in experiment I, 1000 μg/mL was chosen as top dose for experiment II. - Vehicle / solvent:
- - Vehicle used: deionised water
- Justification for choice of solvent/vehicle: The solvent was chosen based on the solubility properties of the test substance and its relative nontoxicity to the cell cultures.. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- other: Demecolcine
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: duplicate
- Number of independent experiments : two (pre-experiment/experiment I and experiment II)
METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 4 h (pulse exposure = pre-experiment/experiment I); 20 h (continuous exposure = experiment II)
- Fixation time (start of exposure up to fixation or harvest of cells): 40 h
FOR CHROMOSOME ABERRATION AND MICRONUCLEUS:
- If cytokinesis blocked method was used for micronucleus assay: Cytochalasin B, 4 μg/mL, 20 h incubation time
- Methods of slide preparation and staining technique used including the stain used: After separation by centrifugation, cells were resuspended in fixative (ice-cold methanol and glacial acetic acid (19 parts plus 1 part, respectively)) and kept cold. The slides were prepared by dropping the cell suspension in fresh fixative onto a clean microscope slide. Cells were stained with Giemsa.
- Number of cells spread and analysed per concentration: At least 1000 binucleate cells per culture, in duplicate cultures, i.e. at least 2000 binucleate cells per concentration.
- Criteria for scoring micronucleated cells: The micronuclei were counted in cells showing a clearly visible cytoplasm area. The micronuclei have to be stained in the same way as the main nucleus. The area of the micronucleus should not extend the third part of the area of the main nucleus. The criteria for the evaluation of micronuclei are described in the publication of Countryman and Heddle, 1976 (COUNTRYMAN P.I. and HEDDLE J.A. (1976) The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutation Research, 41, 321-332).
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: cytokinesis-block proliferation index (CBP)
- Any supplementary information relevant to cytotoxicity: The CBPI was determined in 500 cells per culture and cytotoxicity is expressed as % cytostasis. - Evaluation criteria:
- A test item is considered to be clearly negative if, in all of the experimental conditions examined:
- None of the test item concentrations exhibits a statistically significant increase compared with the concurrent solvent control
- There is no concentration-related increase
- The results in all evaluated test item concentrations should be within the range of the laboratory historical solvent control data (95% control limit realised as 95% confidence interval).
The test item is then considered unable to induce chromosome breaks and/or gain or loss in this test system.
A test item is considered to be clearly positive if, in any of the experimental conditions examined:
- At least one of the test item concentrations exhibits a statistically significant increase compared with the concurrent solvent control
- The increase is concentration-related in at least one experimental condition
- The results are outside the range of the laboratory historical solvent control data (95% control limit realized as 95% confidence interval).
When all of the criteria are met, the test item is then considered able to induce chromosome breaks and/or gain or loss in this test system. - Statistics:
- The statistical significance was confirmed by the Chi Square Test (p < 0.05) and a linear regression was performed to assess a possible dose dependency in the rates of micronucleated cells.
- Key result
- Species / strain:
- lymphocytes: cultured peripheral human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Only in experiment II in the absence of S9 mix, moderate cytotoxicity (29.8% cytostasis) was observed at the highest evaluated concentration.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: The effect of pH was checked; pH did not impact the results.
- Data on osmolality: The effect of osmolality was checked; osmolality did not impact the results.
- Precipitation and time of the determination: Pre-experiment/experiment I: Precipitation observed at 127 μg/mL and above in the absence of S9 mix and at 72.6 μg/mL and above in the presence of S9 mix at the end of treatment. Experiment II: Precipitation observed at 198 µg/mL and above in the absence of S9 mix at the end of treatment.
RANGE-FINDING/SCREENING STUDIES:
Since the range finding pre-experiment fulfilled all validity criteria, it was consider as experiment I which is detailed in sections above.
STUDY RESULTS
Detailed study results are provided in 'Any other information on results incl. tables'.
HISTORICAL CONTROL DATA:
Historical control data are provided in 'Any other information on results incl. tables'. - Conclusions:
- Interpretation of results: negative
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 Sept - 25 Oct 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test using the Hprt and xprt genes)
- Version / remarks:
- adopted in 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- adopted in 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Version / remarks:
- adopted in 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Wiesbaden, Germany
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
- Target gene:
- HPRT locus
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: V79 cells (supplied by Laboratory for Mutagenicity Testing; Technical University Darmstadt, 64287 Darmstadt, Germany)
- Suitability of cells: V79 cells exhibit a high proliferation rate and a good cloning efficiency of untreated cells (as a rule more than 50%). Both these properties are necessary for the appropriate performance of the study. Moreover, the cells have a stable karyotype with a modal chromosome number of 22.
For cell lines:
- Absence of Mycoplasma contamination: Checked regularly
- Methods for maintenance in cell culture: Thawed stock cultures were propagated at 37 °C in 75 cm2 plastic flasks. About 2 - 3 × 10E06 cells were seeded into each flask with 15 mL of minimal essential medium (MEM) containing Hank’s salts supplemented with 10% fetal bovine serum (FBS), neomycin (5 μg/mL) and amphotericin B (1%). All incubations were done at 37 °C with 1.5% carbon dioxide (CO2) in humidified air.
- Cell cycle length, doubling time or proliferation index: doubling time 12 - 16 h in stock cultures
- Modal number of chromosomes: 22
- Periodically checked for karyotype stability: yes
MEDIA USED
- Type and composition of media, CO2 concentration, humidity level, temperature: The complete culture medium was MEM containing Hank’s salts, neomycin (5 μg/mL), 10% FBS, and amphotericin B (1%). During treatment no FBS was added to the medium. For the selection of mutant cells the complete medium was supplemented with 11 μg/mL 6-thioguanine (6-TG). All cultures were incubated at 37 °C in a humidified atmosphere with 1.5% CO2 (98.5% air). - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: Cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital/β-naphthoflavone
- concentration or volume of S9 mix and S9 in the final culture medium: 50 µL
- quality controls of S9 (e.g., enzymatic activity, sterility, metabolic capability): Each batch of S9 was routinely tested for its capability to activate the known mutagens benzo[a]pyrene and 2-aminoanthracene in a bacterial reverse mutation assay (Ames test).
- Lot no.: 310119
- protein concentration: 30.7 mg/mL - Test concentrations with justification for top dose:
- Pre-experiment (+/-S9): 15.6, 31.3, 62.5 125, 250, 500, 1000, 2000 µg/mL
Main experiment (-S9): 0.6, 1.3, 2.5, 5.0, 10.0, 15.0, 22.5, 30.0, 45.0 µg/mL
Main experiment (+S9): 1.9, 3.8, 7.5, 15.0, 30.0, 60.0, 120.0, 240.0 µg/mL
In the pre-experiment a relevant cytotoxic effect, indicated by a relative cloning efficiency of 50% or below was observed at 31.3 μg/mL and above without metabolic activation. In the presence of metabolic activation relevant cytotoxic effects were determined at 250.0 μg/mL and above. The dose range of the main experiment was chosen according to data generated in the pre-experiment. - Vehicle / solvent:
- - Vehicle used: deionised water
- Justification for choice of solvent/vehicle: The solvent was chosen based on the solubility properties of the test substance and its relative nontoxicity to the cell cultures.. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: duplicate
- Number of independent experiments: one main experiment
METHOD OF TREATMENT/EXPOSURE:
- Cell density at seeding: 2 x 10E6
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period: 24 h
- Exposure duration/duration of treatment: 4 h
FOR GENE MUTATION:
- Expression time (cells in growth medium between treatment and selection): approx. 7 days
- Selection details : 4 - 5 x 10E5 cells were seeded in medium containing 6-thioguanine (6-TG, 11 µg/mL) and incubated at 37 ± 1.5°C in a humidified atmosphere with 1.5% ± 0.5 CO2.
- Selection time: 8 - 11 days
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: cloning efficiency
METHODS FOR MEASUREMENTS OF GENOTOXICIY
- Method: mutant frequency - Evaluation criteria:
- A test item is identified as clearly mutagenic if, in any of the experiments performed, all of the following criteria are met:
a) at least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
b) the increase is dose-related when evaluated with an appropriate trend test,
c) any of the results are outside the distribution of the historical negative control data (e.g. Poisson-based 95% control limits).
A test item is identified as clearly non-mutagenic if, in all experiments performed, all of the following criteria are met:
a) none of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
b) there is no concentration-related increase when evaluated with an appropriate trend test,
c) all results are inside the distribution of the historical negative control data (e.g. Poisson-based 95% control limits). - Statistics:
- A linear regression (least squares, calculated using a validated excel spreadsheet) was performed to assess a possible dose dependent increase of mutant frequencies. The number of mutant colonies (mean values) obtained for the groups treated with the test item was compared to the solvent control groups. A trend was judged as significant whenever the p-value (probability value) was < 0.05.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Remarks:
- Precipitation occured at 15 µg/mL without S9 mix and at 60 µg/mL with S9 mix.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: The effect of pH was checked; pH did not impact the results.
- Data on osmolality: The effect of osmolality was checked; osmolality did not impact the results.
- Precipitation and time of the determination: Precipitation at the end of the 4 h treatment period was observed at 15.0 μg/mL without metabolic activation, and at 60.0 μg/mL with metabolic activation.
RANGE-FINDING/SCREENING STUDIES
The pre-experiment was performed in the presence and absence (4 h treatment) of metabolic activation. Test item concentrations between 15.6 μg/mL and 2000 μg/mL were used. A relevant cytotoxic effect, indicated by a relative cloning efficiency of 50% or below was observed at 31.3 μg/mL and above without metabolic activation. In the presence of metabolic activation relevant cytotoxic effects were determined at 250.0 μg/mL and above. Precipitation occurred at 31.3 μg/mL and above after 4 h treatment without metabolic activation, and at 62.5 μg/mL and above with metabolic activation. There was no relevant shift of pH and osmolarity of the medium even at the maximum concentration of the test item.
STUDY RESULTS
Detailed study results are provided in 'Any other information on results incl. tables'.
HISTORICAL CONTROL DATA
Historical control data are provided in 'Any other information on results incl. tables'. - Conclusions:
- Interpretation of results: negative
Referenceopen allclose all
Table 1: Summary of experiment I
Metabolic Activation |
Test Group |
Dose Level (per plate) |
Revertant Colony Counts (Mean ±SD) |
||||
|
|
|
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvrA |
Without Activation |
Deionised water |
|
10 ± 4 |
10 ± 2 |
29 ± 3 |
117 ± 16 |
47 ± 10 |
Untreated |
|
16 ± 3 |
14 ± 4 |
28 ± 8 |
110 ± 3 |
44 ± 9 |
|
Test substance |
3 µg |
12 ± 1 |
12 ± 0 |
25 ± 8 |
109 ± 13 |
34 ± 7 |
|
10 µg |
14 ± 5 |
12 ± 3 |
29 ± 6 |
100 ± 13 |
45 ± 12 |
||
33 µg |
10 ± 3 |
12 ± 5 |
29 ± 9 |
103 ± 11 |
44 ± 3 |
||
100 µg |
12 ± 2 |
8 ± 2 |
33 ± 2 |
90 ± 11 |
37 ± 1 |
||
333 µg |
11 ± 4 |
8 ± 2 |
28 ± 8 |
39 ± 8 |
46 ± 12 |
||
1000 µg |
13 ± 5 |
6 ± 0 |
20 ± 1 |
33 ± 2 |
49 ± 5 |
||
2500 µg |
11 ± 3 P M |
5 ± 1 P M |
15 ± 2 P M |
32 ± 1 P |
44 ± 8 P |
||
5000 µg |
10 ± 1 P M |
3 ± 1 P M |
12 ± 2 P M |
22 ± 2 P M |
49 ± 11 P |
||
NaN3 |
10 µg |
1080 ± 47 |
|
|
1654 ± 91 |
|
|
4-NOPD |
10 µg |
|
|
395 ± 8 |
|
|
|
50 µg |
|
72 ± 10 |
|
|
|
||
MMS |
2.0 µL |
|
|
|
|
1051 ± 12 |
|
With Activation |
Deionised water |
|
11 ± 5 |
14 ± 5 |
34 ± 3 |
116 ± 7 |
43 ± 16 |
Untreated |
|
10 ± 1 |
10 ± 1 |
35 ± 3 |
100 ± 19 |
53 ± 9 |
|
Test substance |
3 µg |
12 ± 3 |
14 ± 6 |
42 ± 7 |
112 ± 19 |
55 ± 8 |
|
10 µg |
12 ± 2 |
11 ± 1 |
44 ± 7 |
124 ± 4 |
52 ± 6 |
||
33 µg |
13 ± 3 |
15 ± 6 |
32 ± 4 |
109 ± 10 |
48 ± 4 |
||
100 µg |
13 ± 2 |
15 ± 2 |
33 ± 3 |
110 ± 15 |
45 ± 6 |
||
333 µg |
11 ± 5 |
17 ± 3 |
37 ± 6 |
87 ± 9 |
53 ± 2 |
||
1000 µg |
12 ± 3 |
10 ± 2 |
43 ± 4 |
69 ± 3 |
51 ± 6 |
||
2500 µg |
10 ± 3 P M |
14 ± 2 P |
32 ± 8 P |
48 ± 7 P M |
49 ± 9 P |
||
5000 µg |
9 ± 3 P M |
6 ± 2 P M |
23 ± 4 P M |
45 ± 7 P M |
48 ± 9 P |
||
2-AA |
2.5 µg |
350 ± 19 |
415 ± 5 |
2845 ± 71 |
3939 ± 86 |
|
|
10.0 µg |
|
|
|
|
297 ± 29 |
Key to positive controls: |
Key to plate postfix codes: |
||
NaN3 |
Sodium azide |
P |
Precipitate |
2-AA |
2-Aminoanthracene |
M |
Manual count |
4-NOPD |
4-Nitro-o-phenylenediamine |
|
|
MMS |
Methylmethanesulfonate |
|
|
Table 2: Summary of experiment II
Metabolic Activation |
Test Group |
Dose Level (per plate) |
Revertant Colony Counts (Mean ±SD) |
||||
|
|
|
TA 1535 |
TA 1537 |
TA 98 |
TA 100 |
WP2 uvrA |
Without Activation |
Deionised water |
|
12 ± 2 |
17 ± 2 |
26 ± 1 |
118 ± 15 |
43 ± 9 |
Untreated |
|
12 ± 3 |
14 ± 5 |
31 ± 3 |
114 ± 7 |
51 ± 8 |
|
Test substance |
3 µg |
|
|
|
112 ± 10 |
|
|
10 µg |
|
17 ± 3 |
24 ± 2 |
118 ± 8 |
|
||
33 µg |
14 ± 5 |
15 ± 0 |
29 ± 9 |
106 ± 2 |
45 ± 13 |
||
100 µg |
13 ± 3 |
12 ± 3 |
30 ± 3 |
102 ± 3 |
40 ± 4 |
||
333 µg |
14 ± 3 |
12 ± 2 |
26 ± 6 |
64 ± 10 |
38 ± 2 |
||
1000 µg |
11 ± 1 |
7 ± 2 |
24 ± 3 |
48 ± 3 |
38 ± 4 |
||
2500 µg |
14 ± 3 P |
7 ± 2 P M |
23 ± 8 P |
49 ± 8 P |
42 ± 9 P |
||
5000 µg |
10 ± 3 P M |
7 ± 3 P M |
18 ± 1 P M |
34 ± 6 P M |
30 ± 2 P |
||
NaN3 |
10 µg |
1224 ± 71 |
|
|
1885 ± 83 |
|
|
4-NOPD |
10 µg |
|
|
400 ± 16 |
|
|
|
50 µg |
|
89 ± 1 |
|
|
|
||
MMS |
2.0 µL |
|
|
|
|
854 ± 57 |
|
With Activation |
Deionised water |
|
12 ± 2 |
14 ± 3 |
34 ± 6 |
114 ± 13 |
49 ± 2 |
Untreated |
|
14 ± 2 |
14 ± 1 |
44 ± 5 |
130 ± 21 |
49 ± 8 |
|
Test substance |
3 µg |
|
|
|
110 ± 19 |
|
|
10 µg |
|
14 ± 3 |
40 ± 4 |
117 ± 6 |
|
||
33 µg |
11 ± 5 |
14 ± 2 |
45 ± 3 |
110 ± 6 |
53 ± 4 |
||
100 µg |
11 ± 3 |
13 ± 2 |
34 ± 1 |
110 ± 9 |
52 ± 6 |
||
333 µg |
11 ± 2 |
14 ± 2 |
36 ± 4 |
113 ± 9 |
52 ± 6 |
||
1000 µg |
13 ± 3 |
15 ± 1 |
32 ± 9 |
87 ± 22 |
56 ± 9 |
||
2500 µg |
11 ± 2 P M |
16 ± 2 P |
29 ± 4 P M |
74 ± 15 P |
53 ± 10 P |
||
5000 µg |
12 ± 2 P M |
11 ± 3 P M |
29 ± 4 P M |
63 ± 3 P M |
59 ± 4 P |
||
2-AA |
2.5 µg |
441 ± 33 |
455 ± 13 |
2763 ± 218 |
4196 ± 204 |
|
|
10.0 µg |
|
|
|
|
313 ± 13 |
Key to positive controls: |
Key to plate postfix codes: |
||
NaN3 |
Sodium azide |
P |
Precipitate |
2-AA |
2-Aminoanthracene |
M |
Manual count |
4-NOPD |
4-Nitro-o-phenylenediamine |
|
|
MMS |
Methylmethanesulfonate |
|
|
Table 3: Historical control data
Strain |
|
|
without S9 mix |
|
|
with S9 mix |
|
||
Mean |
SD |
Min |
Max |
Mean |
SD |
Min |
Max |
||
|
Solvent control |
11 |
2.3 |
6 |
22 |
12 |
2.3 |
7 |
22 |
TA 1535 |
Untreated control |
11 |
2.9 |
6 |
28 |
12 |
2.8 |
7 |
23 |
|
Positive control |
1245 |
161.4 |
367 |
1791 |
398 |
61.0 |
183 |
613 |
|
Solvent control |
10 |
2.2 |
6 |
19 |
13 |
3.2 |
7 |
30 |
TA 1537 |
Untreated control |
10 |
2.7 |
5 |
21 |
14 |
3.6 |
6 |
29 |
|
Positive control |
94 |
30.0 |
48 |
231 |
170 |
64.8 |
81 |
421 |
|
Solvent control |
26 |
4.2 |
13 |
43 |
36 |
6.1 |
12 |
56 |
TA 98 |
Untreated control |
27 |
4.7 |
14 |
40 |
39 |
6.4 |
12 |
59 |
|
Positive control |
421 |
176.8 |
196 |
2068 |
3908 |
815.0 |
223 |
5918 |
|
Solvent control |
160 |
29.3 |
79 |
214 |
148 |
31.3 |
76 |
216 |
TA 100 |
Untreated control |
181 |
26.1 |
80 |
235 |
171 |
27.7 |
87 |
218 |
|
Positive control |
2074 |
262.7 |
511 |
2850 |
3626 |
981.9 |
553 |
5860 |
|
Solvent control |
39 |
6.4 |
26 |
60 |
48 |
7.3 |
28 |
69 |
WP2 uvrA |
Untreated control |
40 |
5.8 |
22 |
61 |
51 |
7.4 |
32 |
87 |
|
Positive control |
865 |
340.9 |
346 |
4732 |
426 |
111.2 |
184 |
1265 |
Mean: mean value of revertants/plate
SD: standard deviation
Min: minimal value
Max: maximal value
These data represent the laboratory´s historical control data from November 2016 until August 2018 representing approx. 600 experiments (for WP2 uvrA the historical data are based on approx. 400 experiments).
Table 1: Summary of results
Experiment |
Preparation interval |
Test item concentration [µg/mL] |
Proliferation index (CBPI) |
Cytostasis [%]* |
Micronucleated cells [%]** |
95% Ctrl limit |
Exposure period 4 h without S9 mix |
||||||
I |
40 h |
Solvent control1 |
1.89 |
|
0.60 |
0.01 – 1.20 |
Positive control2 |
1.66 |
25.5 |
15.00S |
2.66 – 22.74 |
||
41.5 |
1.85 |
4.5 |
0.65 |
|
||
72.6 |
1.78 |
12.7 |
0.50 |
|
||
127P |
1.61 |
31.7 |
1.05 |
|
||
Trend test: p-value 0.282 |
||||||
Exposure period 20 h without S9 mix |
||||||
II |
40 h |
Solvent control1/# |
1.99 |
|
0.33 |
0.00 – 1.14 |
Positive control3 |
1.57 |
42.7 |
3.50S |
1.15 – 6.44 |
||
26.0# |
1.99 |
n.c. |
0.65S |
|
||
39.0# |
1.89 |
10.8 |
0.50 |
|
||
58.5# |
1.70 |
29.8 |
0.85S |
|
||
87.8 |
n.e. |
n.e. |
n.e. |
|
||
Trend test: p-value 0.128 |
||||||
Exposure period 4 h with S9 mix |
||||||
I |
40 h |
Solvent control1 |
1.97 |
|
0.20 |
0.00 – 1.24 |
Positive control4 |
1.39 |
60.2 |
2.95S |
1.01 – 7.34 |
||
23.7 |
1.96 |
1.6 |
0.55 |
|
||
41.5 |
1.98 |
n.c. |
0.20 |
|
||
72.6P |
1.90 |
7.1 |
0.45 |
|
||
Trend test: p-value 0.646 |
* For the positive control groups and the test item treatment groups the values are related to the solvent controls
** The number of micronucleated cells was determined in a sample of 2000 binucleated cells
# The number of micronucleated cells was determined in a sample of 4000 binucleated cells
P Precipitation occurred at the end of treatment
S The number of micronucleated cells is statistically significantly higher than corresponding control values
n.e. Not evaluable, due to strong cytotoxic effects
n.c. Not calculated as the CBPI is equal or higher than the solvent control value
1 Deion. Water 10.0 % (v/v)
2 MMC 0.8 µg/mL
3 Demecolcine 150 ng/mL
4 CPA 20.0 µg/mL
Table 2: Historical control data (percentage of micronucleated cells in human lymphocyte cultures (2018))
Aqueous solvents: DMEM/Ham’s F12, Deionised water (10 % v/v)
Organic solvents: DMSO (0.5 or 1.0 %), Acetone, Ethanol and THF (0.5 %)
Solvent Control without S9 |
||
Micronucleated cells in % |
||
|
Pulse treatment (4/40) |
Continuous treatment (20/40) |
No. of experiments |
69* |
69** |
Mean |
0.60 |
0.53 |
95 % Ctrl limit |
0.01 – 1.20 |
0.00 – 1.14 |
1x SD (2x SD) |
0.30 (0.60) |
0.31 (0.61) |
Min – Max |
0.00 – 1.55 |
0.10 – 1.30 |
* Aqueous solvents – 16 Experiments; Organic solvents – 53 Experiments |
||
** Aqueous solvents – 15 Experiments; Organic solvents – 54 Experiments |
||
Solvent Control with S9 |
||
Micronucleated cells in % |
||
|
Pulse treatment (4/40) |
|
No. of experiments |
70* |
|
Mean |
0.62 |
|
95 % Ctrl limit |
0.00 – 1.24 |
|
1x SD (2x SD) |
0.31 (0.62) |
|
Min – Max |
0.05 – 1.60 |
|
* Aqueous solvents – 16 Experiments; Organic solvents – 54 Experiments |
||
Positive Control without S9 |
||
Micronucleated cells in % |
||
|
Pulse treatment (4/40) |
Continuous treatment (20/40) |
|
MMC |
Demecolcin |
No. of experiments |
69 |
79 |
Mean |
12.70 |
3.80 |
95 % Ctrl limit |
2.66 – 22.74 |
1.15 – 6.44 |
1x SD (2x SD) |
5.02 (10.04) |
1.32 (2.64) |
Min – Max |
3.95 – 28.60 |
1.95 – 8.80 |
Positive Control with S9 |
||
Micronucleated cells in % |
||
|
Pulse treatment (4/40) |
|
|
CPA |
|
No. of experiments |
80 |
|
Mean |
4.18 |
|
95 % Ctrl limit |
1.01 – 7.34 |
|
1x SD (2x SD) |
1.58 (3.17) |
|
Min – Max |
1.80 – 8.85 |
Table 2: Summary of results
Concentration [µg/mL] |
P |
S9 mix |
relative cloning efficiency I [%] |
relative cell density [%] |
rel. Adjusted cloning efficiency I [%] |
mutant colonies / 10E6 cells |
95% confidence interval |
|
Main Experiment / 4 h treatment |
mean values of culture I and II |
|||||||
Solvent control with water |
|
|
- |
100.0 |
100.0 |
100.0 |
9.9 |
2.8 - 30.9 |
Positive control (EMS) |
300.0 |
|
- |
87.5 |
104.1 |
91.4 |
170.0 |
2.8 - 30.9 |
Test item |
0.6 |
|
- |
97.4 |
100.8 |
98.2 |
10.7 |
2.8 - 30.9 |
Test item |
1.3 |
|
- |
101.4 |
100.2 |
102.2 |
8.2 |
2.8 - 30.9 |
Test item |
2.5 |
|
- |
99.5 |
92.5 |
92.2 |
17.2 |
2.8 - 30.9 |
Test item |
5.0 |
|
- |
88.1 |
113.9 |
101.1 |
8.1 |
2.8 - 30.9 |
Test item |
10.0 |
|
- |
89.4 |
87.8 |
78.6 |
14.1 |
2.8 - 30.9 |
Test item |
15.0 |
P |
- |
90.2 |
79.8 |
72.3 |
15.2 |
2.8 - 30.9 |
Test item |
22.5 |
P |
- |
culture was not continued# |
||||
Test item |
30.0 |
P |
- |
culture was not continued# |
||||
Test item |
45.0 |
P |
- |
culture was not continued# |
||||
Solvent control with water |
|
|
+ |
100.0 |
100.0 |
100.0 |
13.5 |
3.1 -30.7 |
Positive control (DMBA) |
2.3 |
|
+ |
88.1 |
102.2 |
88.2 |
332.3 |
3.1 -30.7 |
Test item |
1.9 |
|
+ |
101.8 |
98.3 |
99.8 |
11.7 |
3.1 -30.7 |
Test item |
3.8 |
|
+ |
83.7 |
98.7 |
83.3 |
12.6 |
3.1 -30.7 |
Test item |
7.5 |
|
+ |
92.4 |
115.2 |
106.9 |
12.9 |
3.1 -30.7 |
Test item |
15.0 |
|
+ |
99.8 |
109.3 |
109.3 |
20.2 |
3.1 -30.7 |
Test item |
30.0 |
|
+ |
110.7 |
96.4 |
110.9 |
11.8 |
3.1 -30.7 |
Test item |
60.0 |
P |
+ |
83.7 |
94.2 |
78.7 |
18.3 |
3.1 -30.7 |
Test item |
120.0 |
P |
+ |
culture was not continued# |
||||
Test item |
240.0 |
P |
+ |
culture was not continued# |
P: precipitation at the end of treatment
#: Culture was not continued to avoid analysis of too many precipitating concentrations
Table 3: Historical control data
2014 - 2018 |
||
Number of mutant colonies per 10E6 cells |
||
without metabolic activation (4 h treatment time) |
||
|
Positive control EMS 150 and 300 µg/mL |
Solvent control (medium, acetone, water, DMSO, ethanol, THF, EGDE) |
Range: |
53.9 – 872.3 |
3.4 – 41.0 |
Mean value: |
223.3 |
16.9 |
Standard deviation: |
101.1 |
7.0 |
95% confidence interval |
-- |
2.8 – 30.9 |
Number of studies: |
199 |
199 |
with metabolic activation (4 h treatment time) |
||
|
Positive control DMBA 1.1 and 2.3 µg/mL |
Solvent control (medium, acetone, water, DMSO, ethanol, THF, EGDE) |
Range: |
55.6 – 739.9 |
2.4 – 40.4 |
Mean value: |
188.0 |
16.9 |
Standard deviation: |
98.6 |
6.9 |
95% confidence interval |
-- |
3.1 – 30.7 |
Number of studies: |
193 |
193 |
The 95% confidence interval is derived from the mean value plus/minus 2 times the standard deviation.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
- Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate (all strains)
- Experiment II: 33; 100; 333; 1000; 2500; and 5000 μg/plate (strains TA 1535 and WP2 uvrA), 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate (strains TA 1537 and TA 98), 3; 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate (strain TA 100)
Gene mutation in bacteria in vitro
An in vitro test was performed to investigate the potential of esterification product of C16-C18 even numbered, saturated fatty acids and lactic acid, sodium salt (sodium stearoyl lactylate, SSL, CAS No. 25383-99-7, EC No. 246-929-7) to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II) using the S. typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and the E. coli strain WP2 uvrA. The study was performed according to OECD guideline 471 under GLP conditions (Chang, 2019, Ames) in two independent experiments both with and without liver microsomal activation (S9 mix). Each concentration, the positive and negative controls was tested in triplicate. The test item was tested at the following concentrations:Pre
The test item precipitated in the overlay agar in the test tubes from 1000 to 5000 μg/plate in experiment I and from 2500 to 5000 μg/plate in experiment II. Precipitation of the test item in the overlay agar on the incubated agar plates was observed from 2500 to 5000 μg/plate in both experiments. The undissolved particles had no influence on the data recording. The plates incubated with the test item showed normal background growth up to 5000 μg/plate with and without S9 mix in all strains used. Cytotoxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in experiment I in strains TA 1537, TA 98, and TA 100 and in experiment II in strains TA 1537 and TA 100. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with the test item at any dose level, neither in the presence nor absence of metabolic activation. There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies. In conclusion, under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
Mammalian cell micronucleus test in vitro
The test item esterification product of C16-C18 even numbered, saturated fatty acids and lactic acid, sodium salt (sodium stearoyl lactylate, SSL, CAS No. 25383-99-7, EC No. 246-929-7), suspended in deionised water, was assessed for its potential to induce micronuclei in human lymphocytes in vitro in two independent experiments according to OECD guideline 487 under GLP conditions (Naumann, 2020, MNT). In each experimental group, two parallel cultures were analysed. Per culture at least 1000 binucleated cells were evaluated for cytogenetic damage. The highest applied concentration in this study (2000 μg/mL of the test item) was chosen with regard to the molecular weight of the test item and with respect to the current OECD test guideline. Dose selection of the cytogenetic experiment was performed considering the toxicity data and the occurrence of test item precipitation. In Experiment I, in the absence and presence of S9 mix, no cytotoxicity was observed up to the highest evaluated concentration, which showed precipitation. In Experiment II, in the absence of S9 mix, moderate cytotoxicity (29.8% cytostasis) was observed at the highest evaluated concentration. The next higher tested concentration, however, which was separated by a factor of 1.5 and therefore smaller than requested by the guideline, was not evaluable due to a steep cytotoxic gradient caused by the test item. In Experiment I and II in the absence and presence of S9 mix, no relevant increases in the numbers of micronucleated cells were observed after treatment with the test item. In Experiment II in the absence of S9 mix, however, two values (0.65% and 0.85% micronucleated cells) after treatment with 26.0 and 58.5 μg/mL, respectively, were statistically significantly increased. Since both values are clearly within the range of the 95% control limit of the historical control data (0.00 - 1.14 %) and no dose-dependency, tested by a trend test, was observed, the findings can be regarded as biologically irrelevant. Appropriate mutagens were used as positive controls and induced statistically significant increases in cells with micronuclei. In conclusion, under the experimental conditions reported, the test item did not induce micronuclei as determined by the in vitro micronucleus test in human lymphocytes.
Gene mutation in mammalian cells in vitro
A study according to OECD guideline 476 and under GLP conditions was performed to investigate the potential of esterification product of C16-C18 even numbered, saturated fatty acids and lactic acid, sodium salt (sodium stearoyl lactylate, SSL, CAS No. 25383-99-7, EC No. 246-929-7) to induce gene mutations at the HPRT locus in V79 cells of the Chinese hamster (Sokolowski, 2019, HPRT). The treatment period was 4 h with and without metabolic activation. The maximum test item concentration of the pre-experiment (2000 μg/mL) was chosen with respect to the current OECD test guideline. The concentration range of the main experiment was determined by precipitation and cytotoxicity observed in the pre-experiment. No substantial and dose dependent increase of the mutation frequency was observed in the main experiment. Appropriate reference mutagens (positive controls) induced a distinct increase in mutant colonies and thus demonstrated the sensitivity of the test system and the activity of the metabolic activation system. In conclusion, under the experimental conditions reported, the test item did not induce gene mutations at the HPRT locus in V79 cells.
Justification for classification or non-classification
The available data on genetic toxicity of esterification product of C16-C18 even numbered, saturated fatty acids and lactic acid, sodium salt (sodium stearoyl lactylate, SSL, CAS No. 25383-99-7, EC No. 246-929-7) do not meet the criteria for classification according to Regulation (EC) No. 1272/2008 (CLP) and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.